Medical device and MedTech insights, news, tips and more

CoapTech to Initiate Clinical Trial for its PUMA-G Peds System for Pediatric Gastrostomy

March 8, 2022


CoapTech, Inc, a medical device company focused on delivering transformative solutions for minimally-invasive surgery, announced it has received an Investigational Device Exemption (IDE) approval from the Food and Drug Administration (FDA) to initiate a clinical trial for its PUMA-G Peds System, a device designed to provide a safer and more efficient way to place feeding tubes in children.

The PUMA System™ is a new category of minimally invasive devices, enabling ultrasound procedures in hollow organs of the body where previously it was impossible or unsafe to do so. The PUMA-G Peds System is being developed to allow ultrasound-based placement of gastrostomy tubes in pediatric patients as an alternative to traditional endoscopic, fluoroscopic and open surgical procedures. Endoscopic procedures cannot “see through” tissue which can result in organ damage and other complications exist related to the large sizes of endoscopes relative to small children. Fluoroscopic procedures require the use of ionizing radiation which presents a great risk of future cancer to young children. The PUMA-G Peds System uses ultrasound to visualize tissue and organs in real-time without ionizing radiation.

“We are delighted that the FDA has granted this IDE, allowing us to begin a study with our world-class partner sites. The approval is a testament to our robust preclinical work and the potential of the PUMA-G Peds System to greatly impact pediatric care,” said Jack Kent, Chief Commercialization Officer at CoapTech. The multicenter non-inferiority trial with a matched retrospective control group is part of an NIH SBIR grant and will begin enrolling patients this spring at Children’s Hospital of Philadelphia, Children’s National Medical Center, and Columbia NewYork-Presbyterian Hospital.

CoapTech spun out of the University of Maryland, Baltimore (UMB) where the technology was developed. UMB’s technology transfer arm, UM Ventures, Baltimore, also provided direct investment in the company.

“This is a significant milestone in CoapTech’s efforts to bring to market a pediatric version of their groundbreaking PUMA-G platform technology,” said Phil Robilotto, Associate Vice President for the Office of Technology Transfer at UMB, and Director of UM Ventures, Baltimore. “We look forward to the clinical trial getting underway and seeing what is next for CoapTech.”

About CoapTech
CoapTech is a Baltimore-based medical device company commercializing a new platform called the PUMA System, which allows ultrasound to be utilized in hollow organ cavities. The PUMA (Point-of-care Ultrasound Magnet Aligned) System enables several new minimally invasive, bedside medical procedures, substantially reducing costs while improving patient safety and experience. The platform’s first product application, PUMA-G for ultrasound gastrostomy in adults, has been cleared for use in the U.S. by the FDA via the 510(k) pathway and has received a CE mark. CoapTech was selected as a Medtech Innovator 2019 Best-in-Class Startup company and was named 2018 Maryland Incubator Company of the Year for Best Medical Device Company. Visit for more information or connect via Twitter at @coaptech.

See Full Press Release at the Source: CoapTech Announces IDE Approval from FDA to Initiate Clinical Trial for its PUMA-G Peds System for Pediatric Gastrostomy

Press Release by: CoapTech

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.